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Abstract
Background: Radical prostatectomy is the most common and effective treatment for localized prostate cancer.
Unfortunately, radical prostatectomy is associated with urinary incontinence and has a significant negative impact on
quality of life. Pelvic floor exercises are the most common non-invasive management strategy for urinary incontinence
following radical prostatectomy; however, studies provide inconsistent findings regarding their efficacy. One potential
reason for sub-optimal efficacy of these interventions is the under-utilization of regional muscles that normally co-activate
with the pelvic floor, such as the transverse abdominis, rectus abdominis, and the diaphragm. Two novel approaches to
improve urinary continence recovery are ‘Pfilates’ and ‘Hypopressives’ that combine traditional pelvic floor exercises with
the activation of additional supportive muscles. Our study will compare an advanced pelvic floor exercise training
program that includes Pfilates and Hypopressives, to a conventional pelvic floor exercises regimen for the
treatment of post-radical prostatectomy urinary incontinence.
Methods/Design: This is a pilot, randomized controlled trial of advanced pelvic floor muscle training versus conventional
pelvic floor exercises for men with localized prostate cancer undergoing radical prostatectomy. Eighty-eight men who will
be undergoing radical prostatectomy at hospitals in Toronto, Canada will be recruited. Eligible participants must not have
undergone androgen deprivation therapy and/or radiation therapy. Participants will be randomized 1:1 to receive 26 weeks
of the advanced or conventional pelvic floor exercise programs. Each program will be progressive and have comparable
exercise volume. The primary outcomes are related to feasibility for a large, adequately powered randomized controlled
trial to determine efficacy for the treatment of urinary incontinence. Feasibility will be assessed via recruitment success,
participant retention, outcome capture, intervention adherence, and prevalence of adverse events. Secondary outcomes of
intervention efficacy include measures of pelvic floor strength, urinary incontinence, erectile function, and quality of life.
Secondary outcome measures will be collected prior to surgery (baseline), and at 2, 6, 12, 26-weeks post-operatively.
Discussion: Pfilates and Hypopressives are novel approaches to optimizing urinary function after radical prostatectomy.
This trial will provide the foundation of data for future, large-scale trials to definitively describe the effect of these
advanced pelvic floor exercise modalities compared to conventional pelvic floor exercise regimes for men with
prostate cancer undergoing radical prostatectomy
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Background
Radical prostatectomy (RP) is the most common treatment
for localized prostate cancer (PCa) [1, 2] with a >90 % 15-
year disease-specific survival for men with localized disease
[3]. Unfortunately, RP is associated with post-operative
urinary incontinence (UI) that can persist for two years or
longer and is related to significant reductions in overall
health-related quality of life (QoL) [4–7]. Moreover, UI can
be an important economic burden to patients due to the
cost of pads and lost work productivity [8]. Given the
prevalence of RP in the management of PCa and the associ-
ated psychosocial, functional, and economic adversity
caused by UI, expediting the recovery of urinary control is
a major priority for patients and their clinicians.
Normally, the pelvic floor muscles (comprised of the
internal sphincter, levator ani, coccygeus, striated urogeni-
tal sphincter, external anal sphincter, ischiocavernosus,
and bulbospongiousus) work in a coordinated fashion to
promote urinary control [9, 10]. While the exact etiology
of post-RP UI is not well understood, it is hypothesized to
result from injury to the internal sphincter and/or an onset
of bladder detrusor hyperactivity that can cause urge incon-
tinence through pressure on the bladder walls [10–16].
Consequently, continence becomes dependent on the pelvic
floor musculature that supports the external urethral
sphincter [12, 17, 18], and thus voluntary conditioning of
these muscles is considered a primary, non-invasive UI
management strategy post-RP [19, 20].
Conventional pelvic floor muscle exercises (PFMX) are
intended to improve urinary control by increasing the
strength, endurance, and coordination of the pelvic floor
muscles and functional activation of the external urethral
sphincter [21–23]. Moreover, chronic performance of
PFMXs is suggested to cause hypertrophy of the periure-
thral striated muscles, a resultant stiffening and strength-
ening of the pelvic floor muscles and connective tissues,
Fig. 1 Participant Flow
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and an inhibition reflex of the detrusor muscles [24–26].
Collectively, the PFMXs facilitate improved capability for
external urethral constriction [9] and relaxed detrusor ac-
tivity to aid in the recovery of post-RP UI [27, 28]. PFMXs
typically involve instructions to ‘lift up’ the pelvic floor to
stop the flow of urine [17, 21, 29]. PFMX training starts
with pelvic floor muscle identification through biofeed-
back, typically through active urinary flow control (i.e.
voluntarily starting and stopping urination) and cueing
(using imagery to identify and activate the correct mus-
cles). Once appropriate control is observed, patients are
instructed to practice the same contractions routinely with
a target volume, intensity, frequency, and/or duration [23].
A recent Cochrane review on the management of UI after
RP found a small to moderate benefit of conventional
PFMXs; however, none of the included studies incorporated
training of the surrounding muscles [21]. The paucity of
evidence and modest benefits related to the management of
UI with the engagement of surrounding muscle to the
pelvic floor is salient because of the growing literature dem-
onstrating that pelvic floor muscle contraction is optimized
with co-activation of the abdominals and other regional
muscles [30–34]. In particular, the transverse abdominis
(TrA), rectus abdominis, and diaphragm muscles are often
neglected in PMFX approaches despite their requirement
for optimal pelvic floor activation [30, 33]. The relationship
between the TrA and diaphragm with pelvic floor activation
is described in several lines of research. First, Neumann et
al. [33] observed that relaxation of the abdominal wall dur-
ing pelvic floor muscle contraction only elicits 25 % of the
maximal voluntary contraction of the pelvic floor. Second,
research has indicated that the likelihood of poor pelvic
floor tonic activity (autonomic contraction), and conse-
quent risk of UI, is apparent when the ability of the TrA to
maintain a contraction is impaired [30–32]. Third,
improved tonic activity of the pelvic floor may improve the
autonomic urethral constriction that could prevent leakage
without conscious intervention [35, 36]. Similarly, ‘deep
belly’ breathing exercises that emphasize diaphragmatic
contraction and relaxation have been shown to improve
pelvic floor muscle activation and reduce intra-abdominal
pressure in women with incontinence [30, 37, 38].
More recent PFMX paradigms incorporate techniques
aimed at optimizing pelvic floor muscle responsiveness
and contraction quality through the utilization of other
regional muscles. One such approach is “Pfilates” (‘Pelvic
Floor Pilates’) that incorporates the fundamental elements
of Pilates (a form of exercise that focuses on core strength,
stability, flexibility, and muscle control, as well as posture
and breathing) [39, 40] with targeted pelvic floor activa-
tion [41]. Pfilates includes several static poses that activate
the TrA, hip adductors, gluteal, and pelvic floor muscles
with instructions to pulse (small range of motion) with
short, maximal effort contractions of the engaged muscles.
A recent study by Culligan et al. [40] demonstrated com-
parable improvements in pelvic floor strength measured
by perineometry after 12 weeks of conventional PFMX
versus Pilates in 62 women with little or no pelvic floor
muscle dysfunction. Although UI was not measured, this
study suggests that Pilates may produce similar benefits
for UI as traditional PFMXs.
Another novel approach to PFMXs is known as ‘Hypopres-
sive’ exercises. Hypopressive exercises emphasize engaging
the TrA with conscious coordination of the diaphragm
with breathing that is hypothesized to increase muscle
tone of the pelvic floor muscles and subsequently cause
urethral constriction [30, 42–45]. While executing the pre-
scribed Hypopressive techniques, the use of deep breathing
followed by a brief breath-hold causes relaxation of the dia-
phragm, decrease in intra-abdominal pressure, and a reflex
contraction of the pelvic floor muscles, unconsciously
maximizing a contraction and consequently improving re-
conditioning of these muscles [43, 45]. Caufriez [46] com-
municated this technique in 1997 and described the steps
as follows: slow diaphragmatic inspiration, followed by total
expiration and, after glottal closure, a gradual contraction
of the abdominal wall muscles, with superior displacement
of the diaphragm cupola (referred to as diaphragmatic
aspiration). There is significant attention drawn to the dis-
tension of the ribs, breathing, and body positions, so that
even though one is aware of their pelvic floor, it is an un-
conscious movement [30, 38, 43]. Early research on the
effects of Hypopressive exercise programs have demon-
strated increased tonic activity, strength, and size of the pel-
vic floor muscles via ultrasonography imaging [44].
To date, no study has assessed the effect of a compre-
hensive PFMX regimen that includes Pfilates and Hypo-
pressives for UI. This represents a major gap in our
understanding of non-invasive UI management strategies
for PCa patients especially since the benefits of PFMX are
modest and emerging literature suggests that the pelvic
floor muscles are suboptimally activated during more fo-
cused pelvic floor training.
Methods
This study is a 2-arm, pilot randomized controlled trial
(RCT) that compares the effect of a conventional PFMX
program, considered usual care (UC), to an advanced
pelvic floor exercise program (APFX) including Pfilates,
and Hypopressive for the management of UI after RP for
PCa. The primary objective of this study is to assess the
feasibility of conducting a full-scale RCT of similar design.
Feasibility will be determined via recruitment success,
participant retention, outcome capture, intervention ad-
herence, and prevalence of adverse events. Our secondary
objectives are to compare the efficacy of APFX to UC in
UI, pelvic floor strength, erectile function, and QoL after
RP. This study will be conducted at the Wellness and
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Exercise for Cancer Survivors (WE-Can) program at the
Princess Margaret Cancer Centre. WE-Can is a multidiscip-
linary team of physicians, physiotherapists, kinesiologists,
and other exercise professionals that provide exercise and
physical activity programming for cancer survivors.
This study has been approved by the ethics boards of
the participating institutions and all participants will be
asked to provide voluntary and informed consent.
Study population/participants
Eighty-eight participants will be recruited for this trial. We
anticipate an attrition rate of 20 % by the 26-week follow-
up assessment to yield 70 participants (35 participants per
group) for main efficacy estimate analyses that is aligned
with recommended pilot and feasibility study sample sizes
for treatment effect estimates [47–49]. Inclusion Criteria:
Patients that: i) have localized PCa who have consented for
RP (open retropubic, laparoscopic, or robot-assisted laparo-
scopic); ii) are between the ages of 40 and 80 years; and iii)
are proficient in English. Exclusion Criteria: Patients that: i)
are diagnosed with a known neurological disease, auto-
immune connective tissue disorder; ii) have prior experi-
ence with pelvic floor training by a healthcare provider; iii)
have uncontrolled hypertension; iv) have diagnosed chronic
obstructive pulmonary disease (COPD) and/or chronic
restrictive respiratory disease; v) have a history of inguinal
herniation; or vi) have hypertonic pelvic floor muscles upon
baseline evaluation. Pelvic floor tonicity will be assessed by
a specially trained pelvic floor physiotherapist via digital
rectal examination. Hypertonic pelvic floor is determined
by the physical examination findings of extrapelvic muscu-
loskeletal and connective tissue examination, as well as the
elements of patient history [50]. These patients who exhibit
levator ani hypertonicity (tension myalgia) will be excluded
as they can experience pelvic, urogenital, and rectal pain;
tightness and spasticity; and adverse effects on sexual, urin-
ary, and bowel function that may be exacerbated with
contraction-based pelvic floor training [51, 52].
Study recruitment and randomization
Recruitment will occur in the Greater Toronto Area (total
population 4.5 million) in urological oncology clinics and
through presentations and/or information stands [52] set-
up at local PCa support group meetings. These peer-
support meetings often include men who have been re-
cently diagnosed and are considering various treatments
for PCa, including RP. Men who self-identify as eligible
will receive further verbal and written information about
the study. Those deemed eligible and are interested will be
asked to provide written consent.
Participants will be 1:1 randomized to the UC and
APFX groups, stratified by age (±60 years). Blinded allo-
cation of the participants to their treatment groups will
be performed via a process consisting of placing the
intervention assignments into opaque envelopes, sealing
and shuffling the envelopes, and sequentially numbering
them with each new participant receiving an envelope in
sequence of recruitment. The envelopes will be opened
by the research coordinator with the participant follow-
ing the baseline assessment, prior to RP Fig. 1.
Study arms
The two groups will begin participation in their respective
interventions immediately following post-operative cath-
eter removal until 26-weeks post-operatively. The physio-
therapist assessment of pelvic floor muscle activity and
strength will be assessed during each visit in order to
optimize the quality of the contractions. Instructions to
correctly contract their pelvic floor will be provided
verbally and with biofeedback via the Modified Oxford
Scale (MOS). Grading of this scale is described below. The
research coordinator, who is a Registered Kinesiologist with
training and experience in pelvic floor strengthening, Pfi-
lates, and Hypopressives, will be providing the intervention
prescription for both study arms and will communicate
weekly with the participants to support and quantify pro-
gram compliance (# of completed contractions/# prescribed
contractions), facilitate prescribed progression, and address
any barriers to program participation. Furthermore, both
groups will receive a manual that includes detailed
information and instructions relevant to their training regi-
mens (Tables 1 and 2).
Usual care
The UC group will receive generic PFMX exercise in-
structions and demonstrations from the research coord-
inator at the initial post-operative time point (post-
operative day #10-14) comparable to standard practice
for RP patients at the study site. Participants will be
instructed on how to contract the pelvic floor using
verbal cues and biofeedback (self-observation of urinary
control at the toilet). After the pelvic floor muscles have
Table 1 UC, conventional pelvic floor muscle exercise prescription
Week Positions Reps each position Sets Contractions daily
1 & 2 Lying and sitting 15-20 2-3 30-60
3 & 4 Lying, sitting, and standing 30-40 2-3 60-120
5 & 6 40-50 3 120-150
7 – 26 50-60 3 150-180
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Table 2 Advanced pelvic floor muscle exercise prescription
Week Exercise Position/pose Reps Sets Hold (sec) Pulses (Pfilates only)
1 Kegels Lying and sitting 10-12 3 5-10
Pfilates Butterfly 5 3 3-5 5
Hypopressive Diaphragmatic breathing (lying) 3 3 Fully inhale and exhale
2 Kegels Lying and sitting 10-12 3 5-10
Pfilates Butterfly 5 2 5-8 5
Bridge 5 2 3-5 5
Hypopressive Standing 3 3 5-10
3 Kegels Lying, sitting, and standing 10-12 2 8-10
Pfilates Butterfly 5-10 2 8-10 5-10
Bridge 5-10 2 5-8 5-10
Lunge 5-10 2 3-5 5-10
Hypopressive Standing 3 2 10-15
Kneeling 3 2 5-10
4 Kegels Lying, sitting, standing 10-12 3 8-10
Pfilates Butterfly 8-10 2 10 8-10
Bridge 8-10 2 10 8-10
Lunge 8-10 2 5-8 8-10
Hypopressive Standing 3 1 10-20
Kneeling 3 1 10-15
Downward kneel 3 1 10-15
5 Kegels Lying, sitting, standing 10-12 3 8-10
Pfilates Butterfly 10-12 2 10 10-12
Bridge 10-12 2 10 10-12
Lunge 10-12 2 10 10-12
Hypopressive Standing 3 1 10-30
Kneeling 3 1 10-20
Downward Kneel 3 1 10-20
Sitting 3 1 10-15
6-12 Kegels Lying, sitting, standing 10-12 3 8-10
Pfilates Butterfly 10-12 3 10 10-12
Bridge 10-12 3 10 10-12
Lunge 10-12 3 10 10-12
Hypopressive Standing 3 1 10-30
Kneeling 3 1 10-30
Downward Kneel 3 1 10-30
Sitting 3 1 10-30
12-24 Kegels Lying, sitting and standing 10-15 3 8-10
Pfilates Butterfly 10-15 3 10 10-15
Bridge 10-15 3 10 10-15
Lunge 10-15 3 10 10-15
Hypopressive Standing 3 1 10-30
Kneeling 3 1 10-30
Downward Kneel 3 1 10-30
Sitting 3 1 10-30
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been identified, the UC prescription will consist of max-
imal voluntary contractions with escalating repetition
volume every 2 weeks. Repetition volume will start at
30–60 repetitions per day during weeks 1–2; 60-120/day
during weeks 3–4; and 120-150/day during weeks 5–6,
and 150-180/day for weeks 7–26. Total daily contrac-
tions will be divided into multiple sets over the course
of the day, aiming for 10–20 repetitions per set. The
total number of repetitions will be divided equally be-
tween rhythmic (contract and relaxed over one second)
and sustained contractions (contract and hold for up to
10s and relax). Table 1 provides a detailed description of
the UC PFMX prescription and progression.
Advanced Pelvic Floor Exercise (APFX)
Participants will start with the introduction of basic
PFMX (comparable to UC) with a gradual integration of
Pfilates and Hypopressive exercises until week 12. The Pfi-
lates exercises will progressively integrate postures that
engage and activate supportive abdominal muscles includ-
ing the TrA, hip adductors, and gluteals. During each
pose, participants will be asked to perform a series of
pulses within a small range of motion while maximally
contracting their pelvic floor simultaneously. Similarly, the
Hypopressive techniques are gradually integrated in the
prescription and progressed over 12 weeks. These exer-
cises focus on diaphragmatic breathing and TrA activation
in various static postures. Participants are instructed to
perform three successive slow diaphragmatic inspirations,
followed by a total expiration and apnea (breath hold).
Each apnea will be performed for approximately 10–30
seconds while activating their TrA and intercostal muscles
and rising of their hemidiaphragm [45]. APFX participants
will be gradually progressed in postures and repetition vol-
ume, varying between PFMX, Pfilates, and Hypopressives.
Weeks 13–26 comprise the maintenance stage where pa-
tients will maintain their prescription until the end of the
trial. A detailed week-by-week description of the program
is provided in Table 2 and Appendix A. Total APFX con-
traction volume reflects the volume prescribed in the UC
group following post-operative weeks.
Feasibility assessment
Prior pelvic floor training trials in PCa patients undergo-
ing RP have observed recruitment rates of 21-70 % [21].
We will measure recruitment success through participant
recruitment per week and record reasons for non-
participation from those who inquire about the study and
are eligible to participate but refuse. Adherence to the UC
and APFX program will be measured through a logbook
that is included in their respective manuals as well as a
logbook completed by the research coordinator during the
weekly telephone communication that will compare pre-
scribed to completed volume of contractions. Retention
will be assessed by measuring attrition throughout the
intervention period and at each assessment. We will
monitor and record non-severe and severe adverse events
that occur to participants during the course of this study
using the National Cancer Institute Common Termin-
ology Criteria for Adverse Events version 4.0 [53].
Outcome measures
Participants will complete five study assessments: baseline
(approximately 1 week prior to RP), and at 2, 6, 12, 26-
weeks post-operatively. Each assessment session will take
place in Toronto, Ontario at the Princess Margaret Cancer
Centre in the WE-Can Program. Participant demograph-
ics and self-reported disease and treatment-related vari-
ables will be collected at the baseline assessment.
Urinary incontinence
UI will be assessed using the 24-hour pad test, a 3-day,
bladder diary, and a single-item on the Patient-Oriented
Prostate Utility Scale (PORPUS). The 24-hour pad test will
be used to measure UI by assessing the quantity of urine
lost in one day. A urinary leakage pad is measured after a
24-hour period and compared to the unused pad weight
and is used to assess the severity of UI [54–56]. Patients
will receive their pre-weighed pads (TENA® Men’s Pro-
tective Guards [57]) at baseline with accompanying plastic
zipper storage bags which will be collected at their sched-
uled assessments. Additional pads per assessment will be
provided in case of severe leakage. The pads will be indi-
vidually weighed on an Ohaus® SP2001 (Ontario, Canada)
scale, accurate to +/− 0.1 g. Continence is defined as a loss
of ≤ 2 g of urine or the use of one or less pad per day [56,
58–60]. During the 24-hour period that the pad is worn,
the participants will complete a frequency volume chart in-
cluding urination frequency, times of UI, and if the pad was
ever removed for a period of time. The 3-day bladder diary
is a standard instrument for self-reporting voiding patterns.
Items include fluid intake, frequency of toilet voids, episode
of urine loss, nocturia, number of pads used, and activity
during event for the three-day period. Bladder diaries are
widely used in clinical trials assessing UI after prostatec-
tomy [18, 29, 61–63]. Participants will be instructed to
complete these 3 days prior to their scheduled assessment
appointments. Finally, a single item regarding urinary leak-
age and bladder control is selected from the PORPUS as an
additional self-reported measure of Post-RP UI that has
been used in previous studies [64, 65].
Pelvic floor muscle strength
Digital rectal examination of the pelvic floor by a specially
trained pelvic floor physiotherapist is currently the stand-
ard clinical method for assessing pelvic floor strength and
function [9, 17, 66]. Pelvic floor strength will be performed
in the crook lying position and participants are instructed
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to lift and squeeze the pelvic floor muscles as strongly as
possible for a maximum of 5 seconds. The best of 3 max-
imum contractions is recorded. The quality of contractions
are graded using the 6-point Modified Oxford Scale (MOS)
[67-69]: 0 = no discernible PFM contraction; 1 = flicker, or
pulsing under the examining finger, a very weak contrac-
tion; 2 = a weak contraction, an increase in tension in the
muscle without any discernible lift or squeeze; 3 = a moder-
ate contraction characterized by a degree of lifting of the
posterior pelvic wall and squeezing on the base of the finger
with in-drawing of the perineum; 4 = a good PFM contrac-
tion producing elevation of the posterior pelvic wall against
resistance and in-drawing of the perineum; 5 = a strong
contraction of the PFM; strong resistance can be given
against elevation of the posterior pelvic wall. This will be
measured at baseline (approximately 1 week prior to sur-
gery), and post-operatively at 6, 12, 26-weeks. The MOS
has been used in multiple studies assessing pelvic floor
muscle strength following RP [56, 59, 70, 71].
Body composition
Research has shown that men who are overweight reported
lower post-operative urinary function [72, 73]. Body mass
index (kg/m2) will be calculated using participant’s height
(m) and weight (kg). Body fat percentage will be assessed
by bioelectrical impedance analysis (Tanita© 3000A, Tokyo,
Japan). Waist to hip circumference ratio will be measured
according to the World Health Organization protocol [74].
Waist circumference will be measured with the measuring
tape positioned at the midpoint between lowest margin of
the last palpable rib and the top of the iliac crest and hip
circumference will be measured at the widest girth of the
gluteal region.
Quality of life
PCa-specific QOL will be measured using two widely used
and psychometrically valid and reliable measures: the Func-
tional Assessment of Cancer Treatment-Prostate (FACT-P)
[75] and the PORPUS [75-78]. Additional urological symp-
toms are assessed using the valid and reliable, 7-item Inter-
national Prostate Symptom Score (IPSS) [79, 80]. Erectile
function is assessed using the 5-item International Index
of Erectile Function (IIEF) scale, a widely used, psycho-
metrically validated multidimensional self-report instru-
ment evaluating male sexual function [81, 82].
Physical activity
Recreational physical activity volume will be measured
through the reliable and valid 3-item Godin Leisure-Time
Exercise Questionnaire – Leisure Score Index (GLTEQ-
LSI) [83, 84] . The GLTEQ-LSI assesses the frequency of
mild, moderate, and strenuous bouts of leisure physical
activity or exercise performed for at least 15 minutes over
the past week and has been previously used in trials with
PCa survivors [65, 85].
Statistical analysis
Participant characteristics at baseline will be compared
using independent sample t-tests or chi-square tests. We
will report retention and compliance rates for the sample
and their associated 95 % CI as well as reasons for non-
participation of eligible patients. To calculate outcome
capture, we will calculate the proportion of participants
who have complete data on each outcome at each time
point divided by the total number of study participants.
Estimates of efficacy (Group and Time main effect, as well
as Group x Time interactions) will be analyzed using a
repeated-measure analysis of covariance (ANCOVA), con-
trolling for the baseline value of the outcome of interest.
We will examine the effect size (Cohen’s d) of the inter-
vention on the clinical outcomes by dividing the observed
mean between-group difference in change in the outcome
measure from baseline to follow-up (UC vs. APFX) by its
standard deviation.
Discussion
PFMX continues to be the mainstay for conservative man-
agement of UI after RP; however, its efficacy is modest.
One hypothesis for ineffective PFMX regimens is that the
pelvic floor muscles are not adequately activated because
ancillary pelvic and abdominal muscles are not concur-
rently engaged. Novel techniques to address UI secondary
to pelvic floor muscle weakness and/or RP involve a more
comprehensive strengthening of the pelvic floor and its
surrounding structures. Studies have reported a higher
maximal voluntary contraction of the pelvic floor when
training the pelvic floor muscles and its surrounding mus-
cles simultaneously (i.e. TrA, hip adductors, gluteal, dia-
phragm) [30–34]. These advanced pelvic floor training
techniques include Pfilates and Hypopressives that also
engage the TrA, rectus abdominis, gluteals, diaphragm,
and hip abductors that enhance pelvic floor contraction.
Synergistic training of abdominal and pelvic floor muscles
presents a newer approach to the rehabilitation of pelvic
floor dysfunction following RP.
The primary outcome of this pilot study is to deter-
mine the feasibility of conducting a full-scale RCT of a
comprehensive pelvic floor conditioning program com-
pared to conventional PFMX. Measures of outcome effi-
cacy will also be measured in urinary function, pelvic
floor muscle strength, and QoL. To our knowledge, this
is the first study to examine the effect of a comprehen-
sive PFMX regimen that includes Pfilates and Hypopres-
sives for UI. The above-mentioned training techniques
may prove to be an effective alternative in the conserva-
tive management of UI and the early recovery of contin-
ence after RP.
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Appendix A. Sample cueing instructions for
Pfilates and Hypopressives exercises
Pfilates exercises
Pfilates exercise incorporates a series of poses and plyomet-
ric exercises to compliment pelvic floor muscle training.
This form of neuromuscular conditioning is a therapeutic
alternative for basic pelvic floor muscle exercise that can be
easily integrated into any regular exercise routine. In these
exercises, the engagement of the external hip rotators,
adductors of the thigh, transversus abdominis, and gluteal
muscles will facilitate or induce pelvic floor activation.
For each Pfilates pose will follow a series of identical
phases:
I. The positioning/movement: Here you will position
yourself in the Pfilates pose and perform the
movement a series of repetitions
II. The hold: during this phase you engage the active
muscles and contract your pelvic floor muscles
III.The pulse (plyometric): In this last phase, you will
perform a series of pulses, matching the number of
repetitions in the first phase. (i.e. If you performed 10
repetitions in the movement phase, you will perform
another 10 repetitions in the pulse phase).
Hypopressive exercises
Hypopressives are performed mainly via the transversus
abdominis activation. The goal of these exercises is to
relax the diaphragm, which in turn decreases the intra-
abdominal pressure and may activate the abdominal and
pelvic floor muscles simultaneously.
Each pose will follow a series of identical phases:
I. Positioning of the pose
II. Three diaphragmatic breaths (rest breaths),
described below
III.Apnea (breath hold) of 5-30 seconds
IV.Repeat these steps a total of three times for each
pose
Diaphragmatic breathing (rest breaths) – practice pose
1. Lie on your back on a flat surface with your knees
bent and place your hands on the bottom of your ribs.
2. Breathe in slowly through your nose and open your
upper chest as much as possible. You should feel
your chest flare out ward with your hands.
3. Exhale fully through pursed lips.
Apnea
To perform a correct apnea (breath hold) you must close
your nose and mouth (glottal stop). When you are per-
forming the apnea phase of the exercise, you will have
fully exhaled from your last rest breath. At this point,
with a glottal stop, perform an inhalation without taking
air in. You should feel your stomach and abdomen lift and
squeeze up to your ribcage. Each apnea is held for 10 to
30 seconds.
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